🇺🇸 PEMETREXED DISODIUM HEMIPENTAHYDRATE in United States

70 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Malignant Neoplasm Progression — 10 reports (14.29%)
  2. Off Label Use — 8 reports (11.43%)
  3. Pulmonary Embolism — 8 reports (11.43%)
  4. Renal Impairment — 8 reports (11.43%)
  5. Acquired Gene Mutation — 7 reports (10%)
  6. Pneumonia — 7 reports (10%)
  7. Death — 6 reports (8.57%)
  8. Pulmonary Toxicity — 6 reports (8.57%)
  9. Anaemia — 5 reports (7.14%)
  10. Diarrhoea — 5 reports (7.14%)

Source database →

PEMETREXED DISODIUM HEMIPENTAHYDRATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PEMETREXED DISODIUM HEMIPENTAHYDRATE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PEMETREXED DISODIUM HEMIPENTAHYDRATE in United States?

Marketing authorisation holder not available in our data.